About Our Technology Platform

News
Careers
Contact Us
Search
English
中文 English

Quick find

Home
About Us
About Porton

Founded in July 2005, Porton Pharma Solutions Ltd. (Stock abbreviation: Porton Share; Stock code: 300363) is a leading pharmaceutical CDMO (Contract Development Manufacture Organization) in China. From the early stage of development, Porton has provided global pharmaceutical companies and new drug R&D (Research and Development) institutions with customized R&D.

More
- Porton Profile
  
  Who We Are Our Journey to Excellence Corporate Social Responsibility
- Global Presence
  
  J-Star Research Porton Pharmatech Co., Ltd. Porton Biologics Ltd. Porton Jiangxi
- Corporate Culture
- Contact Us
Porton Video

Recent Activities
Services and Solutions
Small Molecule API and Intermediates CDMO Services

API Process Development
API Manufacturing
API Technology Platform
Quality Studies and Analytical R&D
CMC Registration Support
Drug Product CDMO Services

About Our Drug Product Services
Drug Product Process Development Centers
Drug Product Manufacturing
Analytical Services
Drug Product Technology Platform
Biologics CDMO Services

Gene and Cell Therapy Service
Analytical Development and Quality Control
Support

Client Oriented Program Management
Global Licensing & Partnering: Succeeding Together
Compliance
Compliance

More
- EHS System
- Quality System
- IP Protection
About Porton

Contact Us
Investor Relations
Investor Relations

More
- Corporate Governance
  
  Board of Directors Senior Executives
- Corporate Notices
  
  Quarterly Results CSR Reports
- Investor Service
  
  Dividend and Share Split
Stock Information

2020年3月6日

Porton: 300363

Close：Open：
Contact Us
search
English
中文 English

Drug Product CDMO Services

About Related Services and Solutions

Small Molecule API and Intermediates CDMO Services

Biologics CDMO Services

About Our Technology Platform

Porton thinks in the way of drug development, and the issues that may meet in different stages, and utilize the experiences from the team and projects that we have served to build up the technology platform, aiming to provide stable process to exceed customer’s expectation to help them launching the drug successfully.